BCRX BioCryst Pharmaceuticals
- 4.450
- -0.030-0.67%
- 4.978
- +0.528+11.87%
BioCryst Pharmaceuticals News
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Thackray Helen M.
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MILANO VINCENT
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HEGGIE THERESA
BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Felix J. Baker(4.98%),Julian C. Baker(4.98%), etc.
BioCryst Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Avoro Capital Advisors LLC(6.4%),Behzad Aghazadeh(6.4%)
BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.67%)
BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.1%)
BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(6.24%)
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Stonehouse Jon P
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Thackray Helen M.
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Stonehouse Jon P
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Gayer Charles K
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Doyle Anthony
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Barnes Alane P
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Thackray Helen M.
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Stonehouse Jon P
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Gayer Charles K
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Doyle Anthony
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Barnes Alane P
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MILANO VINCENT
Analysis
Price Target
No Data
